ABAndrew Baker

Andrew Baker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew Baker has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Abstract B038: Preclinical efficacy of KRASG12C inhibitors in models of pediatric cancer

    by Hannah Price, Stacey Stauffer, Katie Powell, Andrew Baker, Andrew Perciaccante, Edjay Ralph Hernandez, Patience Odeniyide, Christine Pratilas, William Burgan, Lisa Jenkins, et al.

    Directly targeting RAS is a desirable approach for treating RAS-mutated tumors because direct RAS inhibitors block all RAS effector pathways simultaneously. Recently, several groups have developed agents that directly target KRAS by covalently modifying KRASG12C. KRAS is commonly altered in adult malignancies such as lung, pancreatic, and colorectal adenocarcinoma, but is less commonly altered in pediatric cancer. However, rare pediatric tumors harboring K-, H-, or NRASG12C are observed. The efficacy of KRASG12C inhibitors in pediatric malignancies is currently unknown, and the ability of these drugs to modify H- and NRASG12C has been incompletely characterized. Here we show that the KRASG12C inhibitors AMG 510, MRTX849, and ARS-1620 slow the release of GDP from H-, N-, and KRASG12C in vitro. Using RASless MEFs, we show that the activity of AMG 510 is specific for H-, N- or KRASG12C, while MRTX849 has both G12C and RAS-independent effects on cell viability. The KRASG12C inhibitors decreased cell viability in KRAS-mutant cell lines derived from patients with the pediatric solid tumor neuroblastoma. MRTX849 was more potent than AMG 510 in neuroblastoma cell lines but was less efficacious and less G12C-specific. The KRASG12C inhibitors also decreased cell viability in an NRASG12C-mutant T-cell ALL cell line derived from an adolescent patient but only MTRX849 decreased cell viability in an HRASG12C-mutant rhabdomyosarcoma cell line. These results suggest that KRASG12C inhibitors may be a treatment option for pediatric patients with H-, N- or KRASG12C mutant solid tumors or leukemia. Future studies will be aimed at testing the efficacy of these inhibitors in xenograft models of pediatric cancer and identifying non-RAS targets of MRTX849. Citation Format: Hannah Price, Stacey Stauffer, Katie Powell, Andrew Baker, Andrew Perciaccante, Edjay Ralph Hernandez, Patience Odeniyide, Christine Pratilas, William Burgan, Lisa Jenkins, Kent L. Rossman, Marielle Yohe. Preclinical efficacy of KRASG12C inhibitors in models of pediatric cancer [abstract]. In: Proceedings of the AACR Special Conference: Targeting RAS; 2023 Mar 5-8; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Res 2023;21(5_Suppl):Abstract nr B038.

  • Open Access

    Data from Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor α

    by Soon Young Shin, Ji Ho Kim, Andrew Baker, Yoongho Lim, Young Han Lee

    Matrix metalloproteinase-9 (MMP-9) is involved in a wide range of normal and pathologic conditions, including inflammation, tissue repair, tumor invasion, and metastasis. Tumor necrosis factor α (TNFα) is a major proinflammatory cytokine that plays crucial roles in tumor progression, including tumor invasion and metastasis in the tumor microenvironment. Egr-1 is a member of the zinc-finger transcription factor family induced by diverse stimuli, including TNFα. However, the role of Egr-1 in MMP-9 expression was previously unknown. This study shows that Egr-1 directly binds to the MMP-9 promoter and plays an essential role for TNFα induction of MMP-9 transcription. Furthermore, Egr-1 together with NF-κB can synergistically activate both basal and TNFα-induced MMP-9 promoter activities in the presence of p300. We found that Egr-1 mediates extracellular signal–regulated kinase and c-jun NH2-terminal kinase mitogen-activated protein kinase–dependent MMP-9 transcription on TNFα stimulation. The requirement for Egr-1 in MMP-9 expression is further supported by the fact that HeLa cells expressing Egr-1 siRNA and Egr-1–null mouse embryonic fibroblasts were refractory to TNFα-induced MMP-9 expression. This report establishes that Egr-1 is essential for MMP-9 transcription in response to TNFα within the tumor microenvironment. Mol Cancer Res; 8(4); 507–19. ©2010 AACR.

  • Open Access

    Data from Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor α

    by Soon Young Shin, Ji Ho Kim, Andrew Baker, Yoongho Lim, Young Han Lee

    Matrix metalloproteinase-9 (MMP-9) is involved in a wide range of normal and pathologic conditions, including inflammation, tissue repair, tumor invasion, and metastasis. Tumor necrosis factor α (TNFα) is a major proinflammatory cytokine that plays crucial roles in tumor progression, including tumor invasion and metastasis in the tumor microenvironment. Egr-1 is a member of the zinc-finger transcription factor family induced by diverse stimuli, including TNFα. However, the role of Egr-1 in MMP-9 expression was previously unknown. This study shows that Egr-1 directly binds to the MMP-9 promoter and plays an essential role for TNFα induction of MMP-9 transcription. Furthermore, Egr-1 together with NF-κB can synergistically activate both basal and TNFα-induced MMP-9 promoter activities in the presence of p300. We found that Egr-1 mediates extracellular signal–regulated kinase and c-jun NH2-terminal kinase mitogen-activated protein kinase–dependent MMP-9 transcription on TNFα stimulation. The requirement for Egr-1 in MMP-9 expression is further supported by the fact that HeLa cells expressing Egr-1 siRNA and Egr-1–null mouse embryonic fibroblasts were refractory to TNFα-induced MMP-9 expression. This report establishes that Egr-1 is essential for MMP-9 transcription in response to TNFα within the tumor microenvironment. Mol Cancer Res; 8(4); 507–19. ©2010 AACR.

  • Open Access

    Homotopy theory of modules over a commutative $S$-algebra: some tools and examples

    by Andrew Baker

    Modern categories of spectra such as that of Elmendorf et al equipped with strictly symmetric monoidal smash products allows the introduction of symmetric monoids providing a new way to study highly coherent commutative ring spectra. These have categories of modules which are generalisations of the classical categories of spectra that correspond to modules over the sphere spectrum; passing to their derived or homotopy categories leads to new contexts in which homotopy theory can be explored. In this paper we describe some of the tools available for studying these `brave new homotopy theories' and demonstrate them by considering modules over the $K$-theory spectrum, closely related to Mahowald's theory of $bo$-resolutions. In a planned sequel we will apply these techniques to the much less familiar context of modules over the $2$-local connective spectrum of topological modular forms.

  • Open Access

    Power operations in $K$-theory completed at a prime

    by Andrew Baker

    We describe the action of power operations on the $p$-completed cooperation algebras $K^\vee_0 K = K_0(K)\sphat_p$ for $K$-theory at a prime~$p$, and $K^\vee_0 KO = K_0(KO)\sphat_2$.

  • Open Access

    The realizability of some finite-length modules over the Steenrod algebra by spaces

    by Andrew Baker, Tilman Bauer

    The Joker is an important finite cyclic module over the mod-$2$ Steenrod algebra $\mathcal A$. We show that the Joker, its first two iterated Steenrod doubles, and their linear duals are realizable by spaces of as low a dimension as the instability condition of modules over the Steenrod algebra permits. This continues and concludes prior work by the first author and yields a complete characterization of which versions of Jokers are realizable by spaces or spectra and which are not. The constructions involve sporadic phenomena in homotopy theory ($2$-compact groups, topological modular forms) and may be of independent interest.

  • Open Access

    Midshaft radius and ulnar fractures

    by Andrew Baker

    ​The degree of angulation in forearm fractures is a key determinant for management. In this case, the angulation was greater than acceptable, and could not be maintained in an adequate position following closed reduction. Hence, ORIF with Titaniu...